The recombinant anti-TNF-α fusion protein ameliorates rheumatoid arthritis by the protective role of autophagy

The currently used anti-cytokine therapeutic antibodies cannot selectively neutralize pathogenic cytokine signaling that cause collateral damage to protective signaling cascades carrying the potential for unwanted side effects. The variable domains of heavy-chain only antibodies (HCAbs) discovered i...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xiaole, Nie, Kaimei, Zhang, Xin, Tan, Shuangyu, Zheng, Qingmei, Wang, Yaduan, Chen, Xiaofeng, Tang, Zhiyu, Liu, Rui, Yan, Mengru, Liu, Zhiwei, Lin, Jianbo, Xu, Jianhua, Zhang, Nanwen, Wang, He, Yang, Juhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2020
Materias:
Immunology & Inflammation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502693/
https://www.ncbi.nlm.nih.gov/pubmed/32880389
http://dx.doi.org/10.1042/BSR20194515

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502693/
https://www.ncbi.nlm.nih.gov/pubmed/32880389
http://dx.doi.org/10.1042/BSR20194515

Ejemplares similares